subject
Biology, 17.04.2020 04:35 helphelp81

A mutation that results in a single amino acid substitution in Ras abolishes its ability to hydrolyze GTP, even when GTPase-activating proteins (GAPs) are present. Approximately 30% of human cancers have this mutation in Ras. The pharmaceutical company AztraZeneca, which markets popular breast cancer drugs like Iressa® (generic: Gefitinib) has recently developed a new drug that prevents the dimerization of a receptor tyrosine kinase expressed in lung cancer cells, which signals via Ras. Would you expect this new drug to be effective for the treatment of cancers that express the mutant form of Ras?

ansver
Answers: 3

Another question on Biology

question
Biology, 21.06.2019 14:50
"acknowledging a right to benefit from the presence of animals requires government action to ensure human access to animals in a number of different spheres," writes jessica pierce, ph.d., in psychology today. the pragmatic meaning of the term "right" in this statement is
Answers: 2
question
Biology, 21.06.2019 20:30
Explain how fossils scientists make discoveries about the lives of organisms and about how environments have changed over time. plz hurry up it time
Answers: 1
question
Biology, 22.06.2019 09:00
What substance is the most acidic. lemon juice. tomato juice. sodium hydroxide. water
Answers: 1
question
Biology, 22.06.2019 17:00
First dropdown options: a. runoff b. condensation c. evaporation second dropdown options: a. photosynthesis b. transpiration c. sweating third dropdown options: a. raindrops b. clouds c. animals
Answers: 1
You know the right answer?
A mutation that results in a single amino acid substitution in Ras abolishes its ability to hydrolyz...
Questions
question
Health, 14.04.2021 21:00
Questions on the website: 13722361